DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy

R Huang, PK Zhou - Signal transduction and targeted therapy, 2021 - nature.com
Genomic instability is the hallmark of various cancers with the increasing accumulation of
DNA damage. The application of radiotherapy and chemotherapy in cancer treatment is …

MRE11-RAD50-NBS1 complex alterations and DNA damage response: implications for cancer treatment

L Bian, Y Meng, M Zhang, D Li - Molecular Cancer, 2019 - Springer
Genome instability is a hallmark of cancer cells and can be accelerated by defects in cellular
responses to DNA damage. This feature of malignant cells opens new avenues for tumor …

DNA damage response mechanisms in head and neck cancer: significant implications for therapy and survival

C Papalouka, M Adamaki, P Batsaki… - International Journal of …, 2023 - mdpi.com
Head and neck cancer (HNC) is a term collectively used to describe a heterogeneous group
of tumors that arise in the oral cavity, larynx, nasopharynx, oropharynx, and hypopharynx …

DNA repair mechanisms, protein interactions and therapeutic targeting of the MRN complex

C McCarthy-Leo, F Darwiche, MA Tainsky - Cancers, 2022 - mdpi.com
Simple Summary The MRN Complex (MRE11-RAD50-NBS1) is responsible for initiating
DNA double-strand break repair and activating several downstream proteins. These proteins …

The emerging role of homologous recombination repair and PARP inhibitors in genitourinary malignancies

KJ Rimar, PT Tran, RS Matulewicz, M Hussain… - Cancer, 2017 - Wiley Online Library
As cells age and are exposed to genotoxic stress, preservation of the genomic code requires
multiple DNA repair pathways to remove single‐strand or double‐strand breaks. Loss of …

Predictors and modulators of synthetic lethality: an update on PARP inhibitors and personalized medicine

S Murata, C Zhang, N Finch, K Zhang… - BioMed research …, 2016 - Wiley Online Library
Poly (ADP‐ribose) polymerase (PARP) inhibitors have proven to be successful agents in
inducing synthetic lethality in several malignancies. Several PARP inhibitors have reached …

Synthetic lethality of PARP inhibition and ionizing radiation is p53-dependent

ST Sizemore, R Mohammad, GM Sizemore… - Molecular Cancer …, 2018 - AACR
PARP inhibitors (PARPi) are potentially effective therapeutic agents capable of inducing
synthetic lethality in tumors with deficiencies in homologous recombination (HR)-mediated …

PTEN inhibition enhances sensitivity of ovarian cancer cells to the poly (ADP-ribose) polymerase inhibitor by suppressing the MRE11-RAD50-NBN complex

L Qiu, R Li, Y Wang, Z Lu, Z Tu, H Liu - British Journal of Cancer, 2024 - nature.com
Background Poly (ADP-ribose) polymerase inhibitors (PARPis) can effectively treat ovarian
cancer patients with defective homologous recombination (HR). Loss or dysfunction of …

The multiple faces of the MRN complex: roles in Medulloblastoma and beyond

M Petroni, V La Monica, F Fabretti, M Augusto… - Cancers, 2023 - mdpi.com
Simple Summary Defects in MRE11A/RAD50/NBS1 (MRN) genes and overexpression of the
MRN proteins are both linked to cancer, generating confusion about how the MRN complex …

Effective biomarkers and radiation treatment in head and neck cancer

TJ Ow, CE Pitts, R Kabarriti… - Archives of Pathology & …, 2015 - meridian.allenpress.com
Context Radiation is a key arm in the multidisciplinary treatment of patients with head and
neck squamous cell carcinoma. During the past 2 decades, significant changes in the way …